Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo. Int J Cancer. 2010 Jun 15; 126(12):2893-903.
View in:
PubMed
subject areas
Adenoviridae
Animals
Blotting, Western
Breast Neoplasms
Cancer Vaccines
Cell Proliferation
Combined Modality Therapy
Drug Synergism
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
Humans
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Protein Kinase Inhibitors
Quinazolines
Receptor, erbB-2
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Tumor Cells, Cultured
Xenograft Model Antitumor Assays